| MeSH term | MeSH ID | Detail |
|---|---|---|
| Dyslipidemias | D050171 | 7 associated lipids |
| Hashimoto Disease | D050031 | 1 associated lipids |
| Hyperparathyroidism, Primary | D049950 | 1 associated lipids |
| Diabetes Complications | D048909 | 4 associated lipids |
| Hypertension, Pregnancy-Induced | D046110 | 2 associated lipids |
| Scleroderma, Limited | D045745 | 1 associated lipids |
| Glucose Metabolism Disorders | D044882 | 3 associated lipids |
| Malnutrition | D044342 | 6 associated lipids |
| Irritable Bowel Syndrome | D043183 | 8 associated lipids |
| Mastocytoma | D034801 | 3 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Morisawa T et al. | Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. | 2015 | Int Heart J | pmid:26549398 |
| Beuselinck B et al. | RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. | 2015 | Br. J. Cancer | pmid:26528707 |
| Rewiuk K and Grodzicki T | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. | 2015 | Biomed Res Int | pmid:26504794 |
| Kassem A et al. | TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. | 2015 | FASEB J. | pmid:26207027 |
| Yang H et al. | A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. | 2015 | Int J Clin Exp Pathol | pmid:26191212 |
| Bortolin RH et al. | Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. | 2015 | PLoS ONE | pmid:25933189 |
| Wei J et al. | Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. | 2015 | Mol Med Rep | pmid:25891179 |
| Su F et al. | Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. | 2015 | Stem Cell Res Ther | pmid:25888745 |
| Son GY et al. | Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. | 2015 | J. Dent. Res. | pmid:25595364 |
| Oostra DR et al. | Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. | 2015 | Mol. Cell. Endocrinol. | pmid:25575458 |